Access to daily spirometry by patients with respiratory diseases such as asthma, COPD or cystic fibrosis can significantly improve the management of their diseases. Regular monitoring of lung health parameters can help reveal the effectiveness of treatments, make early detection of disease progression possible and help patients avoid unnecessary hospital visits. Incorporating advanced ultrasonic sensor technology, Spirohome spirometers precisely detect the quality and reliability of spirometry results.
Overview
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| 500 Emerging Europe | 500ee.co |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Reviews 0
FAQ about Inofab Health
When was Inofab Health founded?
Inofab Health was founded in 2014.
How much funding has Inofab Health raised?
Inofab Health has raised $1.5M in total across 1 funding round.
Who has invested in Inofab Health?
Parsers VC lists 2 investors of Inofab Health, among them 500 Emerging Europe.
Is Inofab Health still active?
Yes, Inofab Health is active.